Genet Med. 2025 Jan 19:101363. doi: 10.1016/j.gim.2025.101363. Online ahead of print.
ABSTRACT
PURPOSE: Limited evidence evaluates parents’ perceptions of their child’s clinical genomic sequencing (GS) results, particularly among individuals from medically underserved groups. Five Clinical Sequencing Evidence-Generating Research (CSER) consortium studies performed GS in children with suspected genetic conditions with high proportions of individuals from underserved groups to address this evidence gap.
METHODS: Parents completed surveys of perceived understanding, personal utility, and test-related distress after GS result disclosure. We assessed outcomes’ associations with child- and parent-related factors: child age; type of GS finding; and parent health literacy, numeracy, and education.
RESULTS: 1763 parents completed surveys; 83% met “underserved” criteria based on race, ethnicity, and risk factors for barriers to access. We observed high perceived understanding and personal utility and low test-related distress. Outcomes were associated with the type of GS finding; parents of children with a pathogenic or likely pathogenic finding endorsed higher personal utility and more test-related distress than those whose child had a variant of uncertain significance (VUS) or normal finding. Personal utility was higher in parents who met criteria for “underserved.”
CONCLUSIONS: Our findings shed light on correlates of parents’ cognitive and emotional responses to their child’s GS findings and emphasize the need for tailored support in disclosure discussions.
PMID:39846247 | DOI:10.1016/j.gim.2025.101363
